Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,002 public trials 1,214 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease

NCT00690430

Conditions
Adenocarcinoma, Carcinoid Tumor, Carcinoma, +8 more
Locations
  • Scottsdale Healthcare/TGen Clinical Research Service TGen Clinical Research Service Scottsdale, Arizona, United States
  • University of Arizona / Arizona Cancer Center Tucson, Arizona, United States
  • Loma Linda University Dept. of Loma Linda CancerCent Loma Linda, California, United States
  • Cedars Sinai Medical Center Cedars Sinai 4 Los Angeles, California, United States
View all 62 locations
View Trial Details
Completed

Safety and Efficacy Study of ALT-801 to Treat Progressive Metastatic Malignancies

NCT00496860

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +66 more
Locations
  • University of Colorado, Anschutz Cancer Pavillion Aurora, Colorado, United States
  • MD Anderson Cancer Center Orlando Orlando, Florida, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • University of Washington, Seattle Cancer Care Center Seattle, Washington, United States
View Trial Details
Completed

Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma

NCT00466687

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States
  • Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details
Completed

Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma

NCT00815607

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • The Angeles Clinic and Research Institute Santa Monica, California, United States
  • Helen F. Graham Cancer Center Newark, Delaware, United States
  • • Nancy N. and J.C. Lewis Cancer Center & Research Pavilion at St. Joseph/Candles Savannah, Georgia, United States
  • Oncology Specialists, S.C. Park Ridge, Illinois, United States
View Trial Details
Completed

Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma

NCT00006258

Conditions
Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, Ependymoma, +13 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Geisinger Medical Center Danville, Pennsylvania, United States
  • Tom Baker Cancer Centre - Calgary Calgary, Alberta, Canada
View Trial Details
Completed

Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors

NCT00002543

Conditions
Brain and Central Nervous System Tumors, Burkitt Lymphoma, Central Nervous System Neoplasms, +33 more
Locations
  • Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
  • Boston Floating Hospital Infants and Children Boston, Massachusetts, United States
  • Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details

Related conditions